The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity Research. Current market leaders include Novo Nordisk NVO and Eli Lilly LLY with ...
A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing ...
Tirzepatide, the main ingredient in Mounjaro and Zepbound, is no longer in shortage, according to the U.S. Food and Drug Administration ... your weight loss,” Jay says. “The best thing ...
New diet drugs are making it easier to lose weight. So does that mean we can stop exercising? Health experts say no. There is ...
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback